European Research inEuropean Research inNanosciences and NanotechnologiesNanosciences and Nanotechnologies

and Perspectives forand Perspectives forInternational Co-operation International Co-operation

Disclaimer: Note that this presentation is not legally binding and does not represent any commitment on behalf of the European Commission

http://cordis.europa.eu/nanotechnology/nicholas.deliyanakis@ec.europa.eu

Nicholas DeliyanakisEuropean Commission

DG Research - G4 : Nano S&T and Converging Science and Technologies

NanotechnologyNanotechnology

Medicine and Health

InformationTechnology

Materials Science

Food, Water and the Environment

InstrumentsEnergy Production / Storage

GMR Hard Disk

Hydrogen Fuel Cells

Lightweight and strong

Drug delivery

Tunneling microscopy

Remediation methods

Potential• to serve society by addressing important problems• to support industrial competitiveness

More knowledge Research Infrastructures Education

Capacity of application Innovation Patents Regulation

Issues to be addressed:Funding and Policy

Reliability Metrology Standards Risk assessment

Societal acceptance Balance and perception of risks and benefits Conformity to ethical principles Expected response to society needs, to people’s expectations and concernssome issues are better

addressed at local, national,EU or global level

Nanosciences and Nanotechnologies: An Action Plan

for Europe 2005-2009

http://cordis.europa.eu/nanotechnology/actionplan.htm

Actions to be implemented by Commission and Member Statesfor integrated, safe and responsible policy:

1. Research & Development2. Infrastructures3. Human Resources4. Industrial Innovation5. Integrating the Societal Dimension6. Public Health, Safety, Environmental and Consumer

Protection7. International Co-operation8. Co-ordination of activities

NMP572

IST466

other36

SME17

NEST22

Health65

Infrastructures40

Marie Curie151

Background: Nanotechnology R&D in FP6Background: Nanotechnology R&D in FP6More than 1.3 billion Euro in more than 550 projects

EC funding by FP6 programme, M€

Nanotechnology R&D in Nanotechnology R&D in the Worldthe World

2004~8 Billion $

2005~10.5 Billion $

Global figures for 2005 M$ (1€ ~ 1.25$)

590

1250

1380450

1000700

10602000

1700

400

0

500

1000

1500

2000

2500

3000

3500

4000

EU US Japan others

Private

States

EC / US federal

Source: EC, Lux Research

NMP FP6 projects, e.g.NMP FP6 projects, e.g.Examples of FP6 projects

•CANAPE: Carbon Nanotubes for Applications in Electronics, Catalysis, Composites and Nano-Biology – University of Cambridge (UK)•NAIMO: Nanoscale Integrated processing of self-organizing Multifunctional Organic Materials - Université Libre de Bruxelles (BE)•NANOFUN-POLY: Nanostructured and functional polymer-based materials and nanocomposites - Consorzio Interuniversitario Scienza e Tecnologia dei Materiali (IT)•RADSAS: Rational Design and Characterisation of Supramolecular Architectures on Surfaces - Eidgenössische Materialprüfungs- und Forschungsanstalt (CH)•BIOMACH: Molecular Machines - Design and Nano-Scale Handling of Biological Antetypes and Artificial Mimics - Forschungszentrum Karlsruhe GmbH (DE)•Cornea engineering: Three-dimensional reconstruction of human corneas by tissue engineering” - Centre National de la Recherche Scientifique / Rhône Alpes (FR)•Ambio: Advanced nanostructured surfaces for the control of biofouling - University of Birmingham (UK)•ANVOC: Application of nanotechnologies for separation and recovery of volatile organic compounds from waste air streams – S&T Research Council of Turkey (TR)•NANOSAFE2: Safe production and use of nanomaterials - Commissariat à l'Energie Atomique (FR)•Nanologue: Facilitating dialogue between research, business and the civil society to improve the quality of life, create wealth and reduce impacts to society - Wuppertal Institute for Climate, Energy and the Environment (DE)

Examples of FP6 projects addressing impact

NANOTOXIMPART www.impart-nanotox.orgNANOSAFE2 www.nanosafe.orgPARTICLE RISK www.iom-world.com/particleriskPOLYSOA polysoa.web.psi.chANTISTORM antistorm.isac.cnr.itDIPNA CELLNANOTOXNANOSHSAPHIRNANOINTERACT

Total Funding for EHS in FP6 ~25 M€

CO-OPERATION 32413-Health 6100-Food, Agriculture and Biotechnology 1935 -Information and Communication Technologies 9050 -Nanosciences, Nanotechnologies, Materials and new Production Technologies 3475 -Energy 2350 -Environment (including Climate Change) 1890 -Transport (including Aeronautics) 4160 -Socio-economic Sciences and Humanities 623 -Space 1430-Security 1400

IDEAS (European Research Council) 7510PEOPLE 4750CAPACITIES 4097JRC 1751

FP7 (EC) Budget, M€

50521 M€

7th FRAMEWORK PROGRAMME 2007-2013

New features of FP7 include:

Longer duration (7 years)

Large increase in annual budget (from ~4,500 to ~7,000M€)

Integration of International Co-operation into all four programmes

Simplification of operation

Focus on developing research that meets the needs of European industry, through the work of Technology Platforms and the new Joint Technology Initiatives

Establishment of a European Research Council, funding European research on the sole basis of excellence

NMP-2007-1.1-1CP

Nano-scale mechanisms of bio/non-bio interactions

NMP-2007-1.1-2CP

Self-assembling and self-organisation

NMP-2007-1.1-3CSA

Support to ICPC researchers in nanotechnology and creation of a free and open electronic archive of nanosciences and nanotechnologies scientific and technical publications

NMP-2007-1.1-4CSA

Development of methodology, collection and elaboration of scientific-technical and socio-economic data and studies on nanosciences and nanotechnologies, including risk assessment, and establishment of an observatory

NMP-2007-1.1-5CSA (ERANET)

ERANET Plus in nanosciences

Funding for Nanotechnology R&D in Funding for Nanotechnology R&D in FP7FP7• More than 50 activities in the calls opened in 2007 are directly relevant• Many more activities are indirectly relevant (e.g. in Health)• 300-400M€ estimated in 2007• Doubling of the FP6 funding expected over duration of FP7NanoscienceNanoscience

NMP-2007-1.2-1Large CP

Pilot lines to study, develop and up-scale nanotechnology-based processes from laboratory

NMP-2007-1.2-2SME-targeted CP

Equipment and methods for nanotechnology

NMP-2007-1.2-4CSA

Coordination in nanometrology

NMP-2007-1.2-5CSA

Examining capacity building in nanobiotechnology

NMP-2007-3.4-1SME-targeted CP

Rapid Manufacturing Concepts for Small Series Industrial Production

NMP-2007-3.5-1Large CP

Processes and Equipment for High Quality Industrial Production of 3-Dimensional Nanosurfaces

NMP-2007-3.5-2Large CP

Production Technologies and equipment for Micro-Manufacturing

NMP-2007-4.0-2SME-targeted CP

Application of new materials including bio-based fibres in high-added value textile products

Technology developmentTechnology development

NMP-2007-1.3-1Large CP

Specific, easy-to-use portable devices for measurement and analysis

NMP-2007-1.3-2CP

Risk assessment of engineered nanoparticles on health and the environment

NMP-2007-1.3-3CSA

Scientific review on the data and studies on the potential impact on health, safety and the environment of engineered nanoparticles

NMP-2007-1.3-4CSA

Creation of a critical and commented database on the health, safety and environmental impact of nanoparticles

NMP-2007-1.3-5CSA

Coordination in studying the environmental, safety and health impact of engineered nanoparticles and nanotechnology based materials and products

HEALTH-2007-1.3-4CP

Alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics

SiS-2007-1.2.3.2-CTCSA

Science in Society: Nanoscience and Nanotechnology

Impact assessment and societal issuesImpact assessment and societal issues

NMP-2007-2.1.1Large CP

Nanostructured polymer-matrix composites

NMP-2007-2.1.2CP

Nanostructured coatings and thin films

NMP-2007-2.1.3CSA

Characterisation of nanostructured materials

NMP-2007-2.2-1Large CP

Organic materials for electronics and photonics

NMP-2007-2.2-2CP

Nanostructured materials with tailored magnetic properties

NMP-2007-2.2.-3CP

Advanced material architectures for energy conversion

NMP-2007-2.4-2CP

Nanostructured catalysts with tailor-made functional surfaces

NMP-2007-2.4-3CP

Renewable materials for functional packaging applications

NMP-2007-2.5-2CP

Modelling of microstructural evolution under work conditions and in materials processing

NanomaterialsNanomaterials

ENERGY-2007.1.2.4CP

Novel nanostructured materials for hydrogen storage

ENERGY-2007.1.1.1CP

Basic research for materials and processes for Polymer Electrolyte Membrane Fuel Cells (PEMFC)

ENERGY-2007.1.1.2CP

Basic research on materials and processes for High Temperature Fuel Cells (SOFC & MCFC)

ENERGY-2007.1.2.1CP

New materials and processes for advanced electrolysers

ENERGY-2007.1.2.2CP

New materials and processes for advanced multi-fuel processors

AAT-2007.1.1.2CP, CSA

Aerostructures

Nanomaterials –cont’dNanomaterials –cont’d

ICT-2007.3.1CP, NoE, CSA

Next generation nanoelectronics components and electronics integration

ICT-2007.8.1CP, CSA (CA only)

Nano-scale ICT devices and systems

NanoelectronicsNanoelectronics

NMP-2007-4.0-4Large CP

Substantial innovation in the European medical industry: development of nanotechnology-based systems for in-vivo diagnosis and therapy (in coordination with topics HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3)

HEALTH-2007-2.4.1-7CP

Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy

HEALTH-2007-1.2.3Large CP

Novel targeted imaging probes for early in vivo diagnosis and/or evaluation of response to therapy

NMP-2007-2.3.-1 Large CP

Highly porous bioactive scaffolds controlling angiogenesis for tissue engineering

NMP-2007-1.2-3CSA

Analysis of the ethical, regulatory, social and economic environment of nanomedicine

ICT-2007-5.1Large CP, CSA

Personal Health Systems for Monitoring and Point-of-Care diagnostics

HEALTH-2007-1.4.4Large CP 2nd call

Development of emerging gene therapy tools and technologies for clinical application

NanomedicineNanomedicine

NB: Many more activities in the Health theme are relevant to nanomedicine,e.g. imaging, stem cells and translating research for human health

ICT-2007.3.6CP, NoE, CSA 2nd call

Micro/nanosystems

ICT-2007.3.5CP, NoE, CSA 2nd call

Photonic components and subsystems

ICT-2007-CCP, CSA (CA only)

FET (Future and Emerging Technologies) Open(Open call for bottom-up activities)

AAT-2007.6.1.4CP, CSA

Life-cycle[of air vehicles, including increased use of nanotechnologies]

KBBE-2007-2-3-04CP

Nano-devices for quality assurance, food safety and product properties

KBBE-2007-2-4-04CP

Innovative and safe packaging

KBBE-2007-2-5-02CP

Converging technologies and their potential for the food area

Other Important TopicsOther Important Topics

Please consider also opportunities withinCOST actions (funding for co-ordination activities)http://www.cost.esf.org/

Ideas – European Research CouncilIdeas – European Research Council

Human ResourcesHuman Resources

Infrastructures & SMEsInfrastructures & SMEs

PEOPLE-2007-1-1-ITN Marie Curie Initial Training Networks(all research areas)

PEOPLE-2007-5-2-Awards

Marie Curie Awards(all research areas)

ERC-2007-StG ERC Starting Independent Researcher Grants(all research areas)

Expected in 2nd call

ERC Advanced Investigator Grants(all research areas)

Please consider also the opportunities in educational programmes managed by DG EAChttp://ec.europa.eu/education/programmes/programmes_en.html

INFRA-2007-2.2.1.27Combination CP/CSA

PRINS, Pan-European Research Infrastructures for Nano-structures (from 2006 ESFRI Roadmap)

FP7-SME-2007-1 Research for the benefit of SMEs

a) Optimising the use and development of the best research infrastructures existing in Europe

Co-ordinated calls dedicated to nanotechnology are envisaged

b) Pooling of resources (national, private, European) to support the emergence of new facilities required by the scientific community within the next 10-20 years

-European Strategy Forum on Research Infrastructures (ESFRI): http://www.cordis.europa.eu/esfri/-Integration through Networks of Excellence

Infrastructures Infrastructures actionsactions

a) Workshop on research training in N&N, 14-15 April 2005

cordis.europa.eu/nanotechnology/src/educationworkshop.htm

b) Educational programmes (Erasmus Mundus, Socrates-Erasmus)

e.g. Erasmus Mundus Masters course in N&N

c) Nanotechnology Award (ongoing discussions with Science and Society directorate)

d) Joint initiatives with Marie Curie actions in FP7 are envisaged

Human Resources Human Resources actionsactions

a) Better co-operation between industry and R&D organisations, encouragement of entrepreneurship NanoForum, a European N&N gateway

www.nanoforum.org NanoRoadSME, NanoRoadmap projects Exploitation Strategy Seminars Risk-Sharing Finance Facility (RSFF) Competitiveness and Innovation Programme (CIP)

b) Increased involvement of industry in EU R&D projects, in particular of SMEs 3 Integrated Projects dedicated to SMEs

Industrial Innovation Industrial Innovation actionsactions

c) Digital N&N library Implementation by a support or coordination action in

FP7

d) Pre-normative R&D and metrology for nanotechnology Two projects in NMP, Nano-Strand and Nanotransport;

also addressed in IST

e) Patent systems Cooperation with EPO Working Group on

Nanotechnologye.g. patent regime, patent analysis, expert exchange, patent monitoring

Industrial Innovation Industrial Innovation actionsactions

Industrial InnovationIndustrial Innovation

Patents:

•In 500 FP5 projects (Growth Programme), an average of 0.9 patents per projects were applied for and 0.4 were granted.

•In FP6 so far (sample of 35 projects), about 3 patents per project have been (or will be) filed

• ~45% from IPs• ~55% from STREPs• Most patents in: Nanobiotechnology, esp. nanomedicine, self-assembly, nanotubes,organic electronics, sensors and instruments

ADDRESSING EXPECTATIONS ANDADDRESSING EXPECTATIONS ANDCONCERNS:CONCERNS: A real partnership between science, society and policy is a key element of governance: Open dialogue with open results.

a) Ethical reviews of projects carried out, where needed

b) European Group of Ethics is assessing Nanomedicine (opinion in autumn 2006)

Societal Dimension Societal Dimension actionsactions

c) Studies and foresight activities NanoRoadSME project www.nanoroad.net NanoRoadMap project www.nanoroadmap.it

d) Social dialogue undertaken through funded projects and events Nanologue project www.nanologue.net Nanodialogue project www.nanodialogue.org “Communicating Science, A survival kit for

Scientists”ec.europa.eu/research/science-society/

pdf/communicating-science_en.pdfe) Publicity material in many languages

http://cordis.europa.eu/nanotechnology/src/pressroom.htm

Societal Dimension Societal Dimension actionsactions

a) Declaration or “code of good conduct” – dedicated international dialogue (global meetings in Alexandria (US), 2004, Tokyo, 2006, and Brussels, 2007)

b) Issues of mutual benefit - (i) a new ISO group is operational, (ii) OECD is becoming increasingly active and (iii) a co-ordinated EU/USA call for proposals in (eco)toxicology is being negotiated

c) Database of publications: Addressed in the first FP7 call for proposals

International Cooperation International Cooperation actionsactions

General principles on General principles on international co-operationinternational co-operation

The Commission seeks international debate on nanotechnology-related issues such as public health, safety, environment, consumer protection, risk assessment, metrology, norms, …;

The EU R&D programmes are open to the World; Europe even funds research teams in Third

Countries; Europe promotes the monitoring and sharing at international

level of information related to the scientific, technological, economical & social development of nanotechnology;

Europe strives for an international “code of conduct” for the responsible development of nanotechnology,

and to avoid a “nano-divide”.

Main International Fora and Initiatives on Nanotechnology

ISO, IEEE, Int. Comm.Weights & Measures

standardisation, metrology

IRGC, ICONabout risksindustry-led

OECD CSTPproposed WP on nanotechnology

OECD NESTInanotechnology

indicatorsUNESCO

ethics incl. risk assessment

G8 Carnegie Group

coordinationby ICGB

OECD JM CHEMICALSWP safety nanomaterials

characterisation, metrology, toxicity, …

OECD Global Science Forum World Social Forum

Global (informal)governmental dialogue

on responsiblenanotechnology

incl. governance & societal dialogue

Observatory?

World Economic Forum

APEC, ANF, NEPADmacro-regions

INCindustry-led

Meridian Inst.,UNIDO, NEPADagainst « divide »

a) Creation of a Commission Interservice Group to monitor and oversee the implementation of the Action Plan, see cordis.europa.eu/nanotechnology/src/contacts.htm

It is important to have a regular interaction with Member States (currently: Council Research working party; a “nano” group for international cooperation; and groups for regulation)

b) Reporting: We plan to issue a report at the end of 2007 and one at the end of 2009

c) Activities to foster beneficial applications: addressed in proposals for FP7 calls for proposals

Co-ordination Co-ordination actionsactions

Inter-institutional activityInter-institutional activity

 The Commission’s approach has received strong support from

Council of Ministers

(European Strategy on Nanotechnology)

European Economic and Social Committee

–Opinion CESE 582/2006

European Parliament

–Resolution (2006)392, Sep 06

References

http://cordis.europa.eu/nanotechnology/src/eu_funding.htmhttp://cordis.europa.eu/nanotechnology/src/eu_funding.htm

FP7: FP7: http://cordis.europa.eu/fp7/home_en.html

FP7 calls:FP7 calls: http://cordis.europa.eu/fp7/dc/index.cfm

Nanotechnology homepage:Nanotechnology homepage:http://cordis.europa.eu/nanotechnology/http://cordis.europa.eu/nanotechnology/

Nanosciences and Nanotechnologies:Nanosciences and Nanotechnologies:An Action Plan for Europe 2005-2009An Action Plan for Europe 2005-2009

http://cordis.europa.eu/nanotechnology/actionplan.htmhttp://cordis.europa.eu/nanotechnology/actionplan.htm

Additional informationAdditional informationon nanotechnology:on nanotechnology: